These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6380843)

  • 1. Further purification of neutrophil migration inhibition factor from T lymphocytes (NIF-T): evidence that NIF-T and leukocyte inhibitory factor (LIF) are immunologically distinct.
    Weisbart RH; Chan G; Spolter L; Golde DW
    Clin Immunol Immunopathol; 1984 Sep; 32(3):269-74. PubMed ID: 6380843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil migration inhibition factor from T lymphocytes (NIF-T): partial purification by antibody affinity chromatography and further characterization.
    Weisbart RH; Lusis AJ; Kacena A; Spolter L; Eggena P; Golde DW
    Clin Immunol Immunopathol; 1982 Mar; 22(3):408-18. PubMed ID: 7049465
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of immunoglobulin G on the responsiveness of human neutrophils to soluble staphylococcal protein A-induced neutrophil migration inhibition factor from T-lymphocytes.
    Colburn KK; Wong LG; Ashman RF; Wistar R; Weisbart RH
    Infect Immun; 1980 Dec; 30(3):674-7. PubMed ID: 7014443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).
    Weisbart RH; Billing R
    Immunology; 1980 Apr; 39(4):577-82. PubMed ID: 6991400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil migration inhibition factor from T lymphocytes (NIF-T): selective removal of biologic activity by human peripheral blood neutrophils, myelocytic leukemia cells, and differentiated HL-60 cells.
    Weisbart RH; Lusis AJ; Chan G; Billing R; Ashman RF; Golde DW
    J Immunol; 1982 Jan; 128(1):457-62. PubMed ID: 6976379
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutrophil migration inhibition factor from T lymphocytes (NIF-T): a new lymphokine.
    Weisbart RH; Golde DW; Spolter L; Eggena P; Rinderknecht H
    Clin Immunol Immunopathol; 1979 Dec; 14(4):441-8. PubMed ID: 389500
    [No Abstract]   [Full Text] [Related]  

  • 7. Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils.
    Gasson JC; Weisbart RH; Kaufman SE; Clark SC; Hewick RM; Wong GG; Golde DW
    Science; 1984 Dec; 226(4680):1339-42. PubMed ID: 6390681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on leukocyte migration inhibitory factor production by T lymphocytes in viral hepatitis.
    Szkaradkiewicz A; Kiczka W; Adamek J
    Digestion; 1981; 22(3):138-43. PubMed ID: 7026324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of a lymphoid cell line product with leukocyte inhibitory factor activity.
    Meshulam DH; Blair HE; Wong BL; Charm S; Minowada J; Rocklin RE
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):601-5. PubMed ID: 6952211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of methylprednisolone on the production of neutrophil migration inhibition factor by T lymphocytes (NIF-T).
    Wong LG; Colburn KK; Kacena A; Weisbart RH
    Immunopharmacology; 1981 Jun; 3(2):179-85. PubMed ID: 6972936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
    Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
    Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired response of neutrophils to a lymphokine by sera from patients with connective tissue disease.
    Kenney HM; Weisbart RH; Colburn KK; Abrass CK; Barnett EV; Golde DW
    Infect Immun; 1983 Dec; 42(3):876-81. PubMed ID: 6642668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset.
    Berman JS; Cruikshank WW; Center DM; Theodore AC; Beer DJ
    Cell Immunol; 1985 Oct; 95(1):105-12. PubMed ID: 3161625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of uraemic "middle-sized molecules" on T lymphocyte functions.
    Kálmán K; Löcsey L; Hauck M; Leövey A
    Int Urol Nephrol; 1980; 12(4):367-74. PubMed ID: 6763010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of in vitro irradiation upon LIF productions by ConA stimulated mononuclear cells.
    Sandru G; Veraguth P
    Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1679-83. PubMed ID: 6460724
    [No Abstract]   [Full Text] [Related]  

  • 18. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on leukocyte migration inhibitory factor (LIF) produced by activated T and B cells.
    Szigeti R; Rosén A
    Lymphokine Res; 1988; 7(1):11-20. PubMed ID: 3283466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced human lymphokines that inhibit lymphocyte migration.
    Berman JS; McFadden RG; Cruikshank WW; Center DM; Beer DJ
    J Immunol; 1984 Sep; 133(3):1495-504. PubMed ID: 6379050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.